|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 35/02 | (2006.01) |
| C07K2317/55 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K2319/33 | (2013.01) | ||
| C07K 16/2803 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| C07K2317/24 | (2013.01) | ||
| C07K2319/03 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| C07K2317/622 | (2013.01) | ||
| C07K2317/94 | (2013.01) |
| (11) | Number of the document | 3615146 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18723320.0 |
| Date of filing the European patent application | 2018-04-24 | |
| (97) | Date of publication of the European application | 2020-03-04 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/029107 |
| Date | 2018-04-24 |
| (87) | Number | WO 2018/200496 |
| Date | 2018-11-01 |
| (30) | Number | Date | Country code |
| 201762489258 P | 2017-04-24 | US |
| (72) |
WILTZIUS, Jed, J.W. , US
SIEVERS, Stuart, A. , US
|
| (73) |
Kite Pharma, Inc. ,
2400 Broadway, Santa Monica, CA 90404,
US
|
| (54) | HUMANIZED ANTIGEN-BINDING DOMAINS AGAINST CD19 AND METHODS OF USE |
| HUMANIZED ANTIGEN-BINDING DOMAINS AGAINST CD19 AND METHODS OF USE |